Company Filing History:
2 out of 86 
1 out of 832,912 Years Active: 2020-2025
Title: The Innovations of Hans De Haard
Introduction
Hans De Haard is a notable inventor based in Zwijnaarde, Belgium. He has made significant contributions to the field of biotechnology, particularly in the treatment of muscular dystrophy. With a total of 3 patents to his name, his work has the potential to impact many lives.
Latest Patents
One of Hans De Haard's latest patents involves the development of anti-Flt-1 antibodies for treating Duchenne muscular dystrophy (DMD). This invention provides methods for administering anti-Flt-1 antibodies to individuals suffering from or susceptible to DMD. The goal is to reduce the intensity, severity, or frequency of symptoms associated with this debilitating condition. The patent outlines a method that aims to delay the onset of symptoms, offering hope to those affected by DMD.
Career Highlights
Throughout his career, Hans has worked with various organizations, including Shire Human Genetic Therapies, Inc. His experience in the biotechnology sector has allowed him to focus on innovative solutions for genetic disorders. His dedication to research and development has positioned him as a key figure in the field.
Collaborations
Hans has collaborated with notable professionals in his field, including Dennis Keefe and Natalie De Jonge. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Hans De Haard's contributions to the field of biotechnology, particularly in the treatment of Duchenne muscular dystrophy, highlight his innovative spirit and commitment to improving patient outcomes. His work continues to inspire future advancements in medical research and treatment options.